OKYO Pharma Ltd ADR (NASDAQ:OKYO) — Stock Price
OKYO Pharma Ltd ADR (NASDAQ:OKYO) is currently trading at $1.59 USD, down 1.85% today. Over the past 52 weeks, shares have ranged between $1.34 and $3.27. This page tracks OKYO Pharma Ltd ADR's live share price on the NASDAQ exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see OKYO Pharma Ltd ADR cash flow conversion.
OKYO Pharma Ltd ADR (OKYO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks OKYO Pharma Ltd ADR's daily closing share price and trading volume on the NASDAQ exchange over the past year, giving a clear view of recent price momentum and liquidity.
OKYO Pharma Ltd ADR Income Statement — Revenue, Profit & Earnings by Year
OKYO Pharma Ltd ADR's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $6.69 Million | $2.56K | $7.51 Million | $6.75 Million | $13.00K |
| Gross Profit | $-6.69 Million | $-2.56K | $-7.51 Million | $-6.75 Million | $-13.00K |
| Research & Development | $1.81 Million | $2.25 Million | $8.24 Million | $6.34 Million | $1.61 Million |
| SG&A | — | — | — | — | $4.92 Million |
| Total Operating Expenses | $1.81 Million | $7.19 Million | $8.24 Million | $6.34 Million | $6.22 Million |
| Operating Income | $-8.50 Million | $-7.19 Million | $-15.75 Million | $-13.09 Million | $-6.23 Million |
| EBITDA | $-8.47 Million | $-7.08 Million | $-15.75 Million | $-13.08 Million | $-6.21 Million |
| EBIT | $-8.47 Million | $-7.09 Million | $-15.75 Million | $-13.09 Million | $-6.22 Million |
| Interest Expense | $473.94K | $883.65K | $1.05 Million | $96.69K | $0.00 |
| Income Before Tax | $-8.94 Million | $-7.97 Million | $-16.80 Million | $-13.28 Million | $-6.22 Million |
| Income Tax Expense | $7.99K | $-3.26 Million | $22.42K | $-12.00K | $-787.00K |
| Net Income | $-8.95 Million | $-4.71 Million | $-16.83 Million | $-13.27 Million | $-5.43 Million |
OKYO Pharma Ltd ADR Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes OKYO Pharma Ltd ADR's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Total Assets | $20.98 Million | $3.68 Million | $1.54 Million | $5.20 Million | $4.30 Million |
| Total Current Assets | $20.97 Million | $3.68 Million | $1.54 Million | $5.20 Million | $4.30 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | $6.00 Million | $0.00 | — | — | — |
| Net Receivables | $170.67K | $1.89 Million | $580.94K | $980.08K | $883.43K |
| Inventory | — | — | — | $170.31K | $-1.49K |
| Property, Plant & Equipment | — | — | — | — | $3.98K |
| Goodwill | — | — | — | — | — |
| Total Liabilities | $8.64 Million | $9.23 Million | $7.42 Million | $7.26 Million | $1.35 Million |
| Total Current Liabilities | $8.64 Million | $9.23 Million | $7.42 Million | $7.26 Million | $1.35 Million |
| Long-term Debt | — | — | — | — | — |
| Net Debt | $-14.59 Million | $-1.56 Million | $-826.85K | $-1.83 Million | $-2.70 Million |
| Total Stockholder Equity | $12.34 Million | $-5.55 Million | $-5.88 Million | $-2.05 Million | $2.95 Million |
| Retained Earnings | $-151.97 Million | $-143.02 Million | $-142.52 Million | $-125.70 Million | $-112.43 Million |
OKYO Pharma Ltd ADR Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how OKYO Pharma Ltd ADR generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2026 | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | $-5.94 Million | $-1.81 Million | $-9.49 Million | $-7.70 Million | $-5.47 Million |
| Capital Expenditures | $6.08K | $1.21K | $3.00 | $5.92K | $1.67K |
| Free Cash Flow | $-5.94 Million | $-1.81 Million | $-9.49 Million | $-7.70 Million | $-5.47 Million |
| Investing Cash Flow | $-6.01 Million | $-1.21K | — | $-5.92K | $-1.67K |
| Financing Cash Flow | $25.02 Million | $2.66 Million | $6.21 Million | $9.32 Million | $2.15 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | $1.61 Million | $734.99K | $1.12 Million | $1.29 Million | $1.72 Million |
| Depreciation | $1.82K | $2.56K | $3.87K | $3.80K | $2.33K |
| Change in Cash | $13.03 Million | $734.05K | $-3.22 Million | $1.34 Million | $-4.19 Million |
OKYO Pharma Ltd ADR Earnings History — EPS Actual vs. Analyst Estimates
Track OKYO Pharma Ltd ADR's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Jul 17, 2026 | — | — | — |
| Mar 31, 2026 | — | -0.03 | — |
| Feb 25, 2026 | 0.00 | -0.04 | +100.00% |
| Sep 30, 2025 | — | -0.02 | — |
| Aug 05, 2025 | -0.06 | -0.05 | -20.00% |
| Mar 31, 2025 | — | -0.05 | — |
| Jan 29, 2025 | -0.08 | -0.09 | +11.11% |
| Sep 30, 2024 | — | -0.09 | — |